Display options
Share it on

Addict Genet. 2015 Jul 01;2(1):1-5. doi: 10.1515/addge-2015-0001. Epub 2015 Aug 28.

Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.

Addiction genetics

Kenneth Blum, Mary Hauser, James Fratantonio, Rajendra D Badgaiyan

Affiliations

  1. Department of Psychiatry, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
  2. Divisions of Addiction Services, Dominion Diagnostics,LLC, North Kingstown, RI, USA.
  3. Divisions of Applied Clinical Research & Education, Dominion Diagnostics, LLC, North Kingstown, RI, USA.

PMID: 26807291 PMCID: PMC4720149 DOI: 10.1515/addge-2015-0001

Abstract

The Brain Reward Cascade (BRC) is an interaction of neurotransmitters and their respective genes to control the amount of dopamine released within the brain. Any variations within this pathway, whether genetic or environmental (epigenetic), may result in addictive behaviors as well as altered pain tolerance. While there are many studies claiming a genetic association with addiction and other behavioral infractions, defined as Reward Deficiency Syndrome (RDS), not all are scientifically accurate and in some case just wrong. Albeit our bias, we discuss herein the facts and fictions behind molecular genetic testing in RDS (including pain and addiction) and the significance behind the development of the Genetic Addiction Risk Score (GARSPREDX™), the first test to accurately predict one's genetic risk for RDS.

Keywords: Brain Reward Cascade; DRD2; Gene variations; Genetic Addiction Risk Score; Reward Deficiency Syndrome

References

  1. J Natl Cancer Inst. 1998 Mar 4;90(5):358-63 - PubMed
  2. Neuropsychopharmacology. 2012 Oct;37(11):2531-40 - PubMed
  3. J Abnorm Psychol. 2009 May;118(2):322-34 - PubMed
  4. Mol Psychiatry. 2015 Nov;20(11):1438-47 - PubMed
  5. Transl Psychiatry. 2014 May 20;4:e391 - PubMed
  6. J Behav Addict. 2014 Sep;3(3):149-56 - PubMed
  7. Behav Pharmacol. 2008 Sep;19(5-6):641-9 - PubMed
  8. Arch Gen Psychiatry. 1991 Aug;48(8):757-9 - PubMed
  9. BMC Genet. 2014 Dec 20;15:151 - PubMed
  10. Health Psychol. 2003 Sep;22(5):541-8 - PubMed
  11. Postgrad Med. 2015 Mar;127(2):232-41 - PubMed
  12. Med Hypotheses. 2005;65(4):703-7 - PubMed
  13. J R Soc Med. 1996 Jul;89(7):396-400 - PubMed
  14. Am J Med Genet. 1995 Aug 14;60(4):272-5 - PubMed
  15. Addiction. 2015 Mar;110(3):530-7 - PubMed
  16. J Neurosci. 2013 Jun 12;33(24):10027-36 - PubMed
  17. Neuroscience. 2015 Jan 22;284:998-1010 - PubMed
  18. Nicotine Tob Res. 2007 Dec;9(12):1251-7 - PubMed
  19. Mol Neurobiol. 2014 Dec;50(3):765-96 - PubMed
  20. Clin Neurosci. 1995;3(3):174-81 - PubMed
  21. Funct Neurol. 1995 Jan-Feb;10(1):37-44 - PubMed
  22. J Addict Res Ther. 2014;5:null - PubMed
  23. Psychiatr Clin North Am. 2012 Jun;35(2):495-519 - PubMed
  24. Expert Opin Drug Metab Toxicol. 2011 Jun;7(6):745-52 - PubMed
  25. Genes Brain Behav. 2009 Feb;8(1):86-96 - PubMed
  26. Am J Hum Genet. 1989 Nov;45(5):778-85 - PubMed
  27. Ann Hum Genet. 2014 Jan;78(1):33-9 - PubMed
  28. Pharmacogenet Genomics. 2006 Jan;16(1):1-7 - PubMed
  29. Addict Biol. 2014 Jul;19(4):708-21 - PubMed
  30. Pain Med. 2015 Jan;16(1):119-30 - PubMed
  31. JAMA. 1990 Apr 18;263(15):2055-60 - PubMed

Publication Types

Grant support